The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab

Several Bevacizumab products are approved for clinical use, with many others in late-stage clinical development worldwide. To aid the harmonization of potency assessment across different Bevacizumab products, the first World Health Organization (WHO) International Standard (IS) for Bevacizumab has b...

Full description

Bibliographic Details

Published in:	Biomolecules
Main Authors:	Haiyan Jia, Parvathy Harikumar, Eleanor Atkinson, Peter Rigsby, Meenu Wadhwa
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Subjects:	angiogenesis Bevacizumab bioassay biosimilar HUVEC international standard
Online Access:	https://www.mdpi.com/2218-273X/11/11/1610